Feedback

Cardiac Pharmacology

Thomas S Metkus, MD, Glenn J.R. Whitman, MD
Cardiac Pharmacology is a topic covered in the Adult and Pediatric Cardiac.

To view the entire topic, please or .

STS Cardiothoracic Surgery E-Book from The Society of Thoracic Surgeons provides expert guidance for Cardiac and Thoracic Surgery. Sections include Pearson’s General Thoracic, Esphageal, Adult Cardiac, and Pediatric and Congenital Cardiac Surgery. Explore these free sample topics:

-- The first section of this topic is shown below --

Introduction

Drug therapy has revolutionized treatment for patients with cardiovascular disease, and patients presenting for cardiac surgery are prescribed a myriad of pharmacotherapies to manage their underlying cardiac disease; to treat them during the pre-, intra- and postoperative periods; and to optimize long-term patient outcomes after cardiac surgical intervention. In modern cardiac surgical practice, an understanding of optimal drug therapy for each phase of care for these patients is crucial. In this chapter, we will review the mechanism of action, clinical effects, common indications, and underlying evidence, when available, for commonly prescribed drug classes in cardiac surgical practice, including antiplatelet agents, anticoagulants, anti-arrhythmic drugs, thrombolytic therapies, as well as lipid management and vasoactive medications.

-- To view the remaining sections of this topic, please or --

Introduction

Drug therapy has revolutionized treatment for patients with cardiovascular disease, and patients presenting for cardiac surgery are prescribed a myriad of pharmacotherapies to manage their underlying cardiac disease; to treat them during the pre-, intra- and postoperative periods; and to optimize long-term patient outcomes after cardiac surgical intervention. In modern cardiac surgical practice, an understanding of optimal drug therapy for each phase of care for these patients is crucial. In this chapter, we will review the mechanism of action, clinical effects, common indications, and underlying evidence, when available, for commonly prescribed drug classes in cardiac surgical practice, including antiplatelet agents, anticoagulants, anti-arrhythmic drugs, thrombolytic therapies, as well as lipid management and vasoactive medications.

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: February 22, 2020